2017
DOI: 10.1016/j.jdiacomp.2017.06.002
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of plasma pigment epithelium-derived factor (PEDF), retinol binding protein 4 (RBP-4), chitinase-3-like protein 1 (YKL-40) and brain-derived neurotrophic factor (BDNF) for the identification of insulin resistance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
14
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(14 citation statements)
references
References 41 publications
0
14
0
Order By: Relevance
“…Besides, plasma CHI3L1 level was not associated with insulin resistance in a human study using hyperinsulinemic-euglycemic clamp. 45 A study by Park et al 46 conducted in Koreans showed higher CHI3L1 levels in diabetic patients compared to nondiabetic F I G U R E 8 Associations among plasma CHI3L1 levels, CHI3L1 genetic variants, and lymphocytic CHI31L mRNA expression. A, Plasma CHI3L1 levels of young NGT (n = 20) and old NGT (n = 20).…”
Section: Discussionmentioning
confidence: 99%
“…Besides, plasma CHI3L1 level was not associated with insulin resistance in a human study using hyperinsulinemic-euglycemic clamp. 45 A study by Park et al 46 conducted in Koreans showed higher CHI3L1 levels in diabetic patients compared to nondiabetic F I G U R E 8 Associations among plasma CHI3L1 levels, CHI3L1 genetic variants, and lymphocytic CHI31L mRNA expression. A, Plasma CHI3L1 levels of young NGT (n = 20) and old NGT (n = 20).…”
Section: Discussionmentioning
confidence: 99%
“…The study included 18 participants between 33 and 76 years old, selected from a project about new biomarkers of insulin resistance (34). Exclusion criteria were known diabetes mellitus or use of antidiabetic medications, other endocrine disorders, diseases of the exocrine pancreas, pregnancy or use of oral anticoagulants or lipid-lowering drugs.…”
Section: Study Design and Participantsmentioning
confidence: 99%
“…It is known that besides apoA-I (the natural cofactor of LCAT) (31), apoE is able to activate LCAT in vitro (32), while an increase in the apoC-III content of synthetic HDL exerts the opposite effect (33). ApoE is able to partially rescue LCAT activity In apoA-I knockout mice, albeit only in VLDL and LDL, not in HDL (34). Despite their major relevance in lipoprotein metabolism, the in uence of apoE and apoC-III over LCAT and CETP in humans is very poorly understood.…”
Section: Introductionmentioning
confidence: 99%
“…We studied 18 patients (8 male, 10 female) aged 33 to 76, selected from a project about new biomarkers of insulin resistance (34). We excluded individuals with known diabetes mellitus or use of anti-diabetic medications, other endocrine disorders, diseases of the exocrine pancreas, pregnant women or patients who received oral anticoagulants or lipid-lowering drugs.…”
Section: Study Design and Participantsmentioning
confidence: 99%
“…It is known that besides apoA-I (the natural cofactor of LCAT) (31), apoE is able to activate LCAT in vitro (32), while an increase in the apoC-III content of synthetic HDL shows the opposite effect (33). In apoA-I knockout mice, apoE is able to partially rescue LCAT activity, albeit in VLDL and LDL, not in HDL (34). Despite their major relevance in lipoprotein metabolism, little is known about the influence of apoE and apoC-III over LCAT and CETP in humans.…”
mentioning
confidence: 99%